Form S-4 - Registration of securities, business combinations:
SEC Accession No. 0000950123-05-011310
Filing Date
2005-09-20
Accepted
2005-09-20 16:59:12
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-4 y12516sv4.htm S-4 1641537
2 EX-5.1: OPINION OF SAUL EWING LLP y12516exv5w1.htm EX-5.1 4463
3 EX-23.1: CONSENT OF KPMG LLP y12516exv23w1.htm EX-23.1 2549
4 EX-23.2: CONSENT OF ERNST & YOUNG LLP y12516exv23w2.htm EX-23.2 1715
5 EX-99.1: FORM OF PROXY CARD y12516exv99w1.htm EX-99.1 13208
6 EX-99.2: CONSENT OF MERRILL LYNCH, PIERCE, FENNER & SMITH INCORPORATED y12516exv99w2.htm EX-99.2 4596
8 GRAPHIC y12516y1251600.gif GRAPHIC 1858
9 GRAPHIC y12516y1251601.gif GRAPHIC 1937
10 GRAPHIC y12516y1251603.gif GRAPHIC 1012
11 GRAPHIC y12516y1251602.gif GRAPHIC 2844
  Complete submission text file 0000950123-05-011310.txt   1680728
Mailing Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747
Business Address 58 SOUTH SERVICE RD. SUITE 110 MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1204
Type: S-4 | Act: 33 | File No.: 333-128446 | Film No.: 051094006
SIC: 2835 In Vitro & In Vivo Diagnostic Substances